MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
10.24
-0.07
-0.63%
Pre Market: 10.39 +0.16 +1.51% 04:30 03/16 EDT
OPEN
10.42
PREV CLOSE
10.30
HIGH
10.61
LOW
10.13
VOLUME
104
TURNOVER
0
52 WEEK HIGH
11.97
52 WEEK LOW
5.01
MARKET CAP
1.67B
P/E (TTM)
3.975
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NVAX last week (0309-0313)?
Weekly Report · 1h ago
Assessing Novavax (NVAX) Valuation After Strong 2025 Results And Return To Profitability
Simply Wall St · 4d ago
Novavax Inc. Stock Climbs 5.7%, Outperforms Peers
Dow Jones · 6d ago
Weekly Report: what happened at NVAX last week (0302-0306)?
Weekly Report · 03/09 10:25
Controversial Prasad leaving FDA, NYT reports
TipRanks · 03/08 20:55
FDA vaccine chief to leave the agency again
Seeking Alpha · 03/07 12:41
How Investors Are Reacting To Novavax (NVAX) Swinging From Losses To Profits On Vaccine Revenue
Simply Wall St · 03/07 07:19
Novavax Earnings Call Signals Leaner, Partner-Led Future
TipRanks · 03/06 00:15
More
About NVAX
Novavax, Inc. is a biotechnology company. It is focused on addressing global health challenges through its vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. Matrix-M can be used to create vaccines for a variety of diseases to help tackle some of the pressing health challenges. Its proprietary Matrix-M adjuvant, when added to vaccines, has been shown to help induce a stronger and longer-lasting immune response. Its recombinant protein-based nanoparticle technology has been shown to be highly immunogenetic. Its technology platform is used in its authorized COVID-19 vaccine and the R21/Matrix-M adjuvant malaria vaccine. Its late-stage programs include a COVID-19-Influenzavaccine candidate, and an influenza vaccine candidate. R21/Matrix-M adjuvant malaria vaccine, a malaria vaccine developed by its partner. It provides Matrix-M adjuvant for use in various programs in preclinical and clinical stage, and preclinical investigations.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.